# Tempest Therapeutics, Inc.: Form SC 13D/A, filed Nov 9, 2023

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: SC 13D/A
- Filed: 2023-11-09
- Accepted by EDGAR: Nov 9, 2023, 17:28 ET
- Period: not reported
- Accession: 0001193125-23-274644
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000119312523274644/d582597dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000119312523274644/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000119312523274644/d582597dsc13da.htm

Filed Nov 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-274644. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
